BIOMAT Database Logo BIOMAT Database Logo

[Stabilization of dehydroepiandrosterone enanthate in powder mixtures]. 1974

M Amin, and A Seeger, and K Prezewowsky, and P Fuchs

UI MeSH Term Description Entries
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011208 Powders Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed) Powder
D003687 Dehydroepiandrosterone A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion. Dehydroisoandrosterone,Prasterone,5-Androsten-3-beta-hydroxy-17-one,5-Androsten-3-ol-17-one,Androstenolone,DHEA,Prasterone, 3 alpha-Isomer,5 Androsten 3 beta hydroxy 17 one,5 Androsten 3 ol 17 one,Prasterone, 3 alpha Isomer
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs

Related Publications

M Amin, and A Seeger, and K Prezewowsky, and P Fuchs
[Therapy of psoriasis using dehydroepiandrosterone-enanthate].
February 1972, Zeitschrift fur Haut- und Geschlechtskrankheiten,
M Amin, and A Seeger, and K Prezewowsky, and P Fuchs
Failure of dehydroepiandrosterone enanthate to promote growth.
June 1986, The Journal of clinical endocrinology and metabolism,
M Amin, and A Seeger, and K Prezewowsky, and P Fuchs
[Steroids in plasma and urine after i.m. injection of dehydroepiandrosterone-enanthate].
July 1971, Arzneimittel-Forschung,
M Amin, and A Seeger, and K Prezewowsky, and P Fuchs
[Dehydroepiandrosterone enanthate and estradiol valerate for the treatment of menopause].
April 1986, Minerva ginecologica,
M Amin, and A Seeger, and K Prezewowsky, and P Fuchs
[Interactive powder mixtures].
July 2004, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti,
M Amin, and A Seeger, and K Prezewowsky, and P Fuchs
Homogeneity of multicomponent powder mixtures.
March 1974, Journal of pharmaceutical sciences,
M Amin, and A Seeger, and K Prezewowsky, and P Fuchs
Wetting of binary powder mixtures.
December 2019, International journal of pharmaceutics,
M Amin, and A Seeger, and K Prezewowsky, and P Fuchs
[Aerosil stabilization of drug mixtures].
January 1980, Farmatsiia,
M Amin, and A Seeger, and K Prezewowsky, and P Fuchs
Anomalies in some properties of powder mixtures.
May 1976, The Journal of pharmacy and pharmacology,
M Amin, and A Seeger, and K Prezewowsky, and P Fuchs
Administration of dehydroepiandrosterone enanthate to oophorectomized women--effects on sex hormones and lipid metabolism.
December 1980, Maturitas,
Copied contents to your clipboard!